February 23, 2025
Moderna/Merck begin late-stage study of mRNA cancer vaccine

Moderna https://www.reuters.com/markets/companies/MRNA.O” target=”_blank” rel=”noopener”>(MRNA.O) and its partner Merck https://www.reuters.com/markets/companies/MRK.N” target=”_blank” rel=”noopener”>(MRK.N) said on Wednesday that they had begun enrolling patient…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *